Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency
- PMID: 318213
- DOI: 10.1093/clinids/1.1.118
Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency
Abstract
The pharmacokinetics of a single intravenous dose of 30 mg of cefoxitin/kg given to normal subjects and to patients with various degrees of chronic renal insufficiency were studied. The serum half-life of cefoxitin was correlated inversely with the rate of creatinine clearance, and the half-life increased exponentially when the creatinine clearance rate fell below 30 ml/min per 1.73 m2. The elimination of cefoxitin into urine was rapid and extensive in patients whose creatinine clearance was greater than 30 ml/min per 1.73 m2. In patients with more severe degrees of renal impairment, renal clearance of drug was diminished markedly (less than 20% of the administered dose was excreted in 4 hr as compared with greater than 60% in the former group). The clearance of cefoxitin can be increased fivefold by hemodialysis in patients with end-stage renal disease.
Similar articles
-
Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.Antimicrob Agents Chemother. 1981 Dec;20(6):741-6. doi: 10.1128/AAC.20.6.741. Antimicrob Agents Chemother. 1981. PMID: 7325641 Free PMC article.
-
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.Antimicrob Agents Chemother. 1988 Apr;32(4):503-9. doi: 10.1128/AAC.32.4.503. Antimicrob Agents Chemother. 1988. PMID: 3377461 Free PMC article.
-
Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.Antimicrob Agents Chemother. 1989 Sep;33(9):1470-6. doi: 10.1128/AAC.33.9.1470. Antimicrob Agents Chemother. 1989. PMID: 2817847 Free PMC article.
-
Pharmacokinetics of cefepime in subjects with renal insufficiency.Clin Pharmacol Ther. 1990 Sep;48(3):268-76. doi: 10.1038/clpt.1990.149. Clin Pharmacol Ther. 1990. PMID: 2401125
-
Pleural fluid levels of cefoxitin in patients with renal impairment.Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):485-9. Int J Clin Pharmacol Ther Toxicol. 1986. PMID: 3781682
Cited by
-
Pharmacokinetics of cefoxitin during haemofiltration.Eur J Clin Pharmacol. 1983;25(3):395-8. doi: 10.1007/BF01037954. Eur J Clin Pharmacol. 1983. PMID: 6628529
-
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003. Clin Pharmacokinet. 1980. PMID: 6105934
-
Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.Eur J Clin Pharmacol. 1985;28(3):333-7. doi: 10.1007/BF00543333. Eur J Clin Pharmacol. 1985. PMID: 4007038
-
Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003. Clin Pharmacokinet. 1984. PMID: 6362952 Review.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.